RACHAEL LOVETT: Open Payments
NPI 1841968088 · PEACHTREE CORNERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $253 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $41 |
| BeOne Medicines USA, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Celgene Corporation | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Exelixis Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: IBRANCE, Enhertu, BRUKINSA, LYNPARZA, XPOVIO, REBLOZYL, MONJUVI, CABOMETYX.
Industry payments across GA — which companies pay providers there.
